Chu Chenghao, Liu Bin, Zhang Yongwei, Xu Zhangxuan, Wang Bin, Chin Kai Ling
Department of General Surgery, Anqing First People's Hospital.
Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah.
Tohoku J Exp Med. 2025 Mar 27;265(3):173-182. doi: 10.1620/tjem.2024.J115. Epub 2024 Nov 7.
Macrophage polarization is implicated in the pathological mechanism of gastric cancer (GC). This study investigated how the miR-668-3p/ Nuclear factor kappa B inhibitor alpha (NFKBIA) axis drives macrophage polarization to contribute to GC progression. Inhibitors or shRNA were used to interfere with the expression of miR-668-3p or NFKBIA in the GC cell line. Subsequently, CCK-8, EdU, wound healing, and transwell assays were used to assess the biological behavior of the GC cells. Bioinformatics analysis predicted the target connection between miR-668-3p and NFKBIA, and a dual luciferase reporter gene experiment confirmed this relationship. After THP-1 macrophages were co-cultured with the supernatant of transfected GC cells, the M1 and M2 macrophage phenotypes were determined. Subsequently, these THP-1 macrophages were co-cultured with GC cells using the Transwell, and the biological behaviors of the GC cells were determiend. miR-668-3p inhibitor suppressed proliferation, invasion and migration of GC cells. The phenotype of M1 macrophage (IL-1β, TNF-α and IL-6) was boosted yet the phenotype of M2 macrophage (CD206, Fizz1 and IL-10) was declined by miR-668-3p inhibitor. NFKBIA was the target gene of miR-668-3p and it reversed the effects of miR-668-3p inhibitor on macrophage polarization and biological behaviors of the GC cells.miR-668-3p suppressed NFKBIA in GC cells to mediate M2 polarization of macrophages, thereby facilitating the tumorigenesis of GC.
巨噬细胞极化与胃癌(GC)的病理机制有关。本研究探讨了miR-668-3p/核因子κB抑制因子α(NFKBIA)轴如何驱动巨噬细胞极化以促进GC进展。使用抑制剂或短发夹RNA(shRNA)干扰GC细胞系中miR-668-3p或NFKBIA的表达。随后,采用CCK-8、EdU、伤口愈合和Transwell实验评估GC细胞的生物学行为。生物信息学分析预测了miR-668-3p与NFKBIA之间的靶向关系,双荧光素酶报告基因实验证实了这种关系。将THP-1巨噬细胞与转染后的GC细胞上清共培养后,测定M1和M2巨噬细胞表型。随后,使用Transwell将这些THP-1巨噬细胞与GC细胞共培养,并测定GC细胞的生物学行为。miR-668-3p抑制剂抑制了GC细胞的增殖、侵袭和迁移。miR-668-3p抑制剂增强了M1巨噬细胞(IL-1β、TNF-α和IL-6)的表型,同时降低了M2巨噬细胞(CD206、Fizz1和IL-10)的表型。NFKBIA是miR-668-3p的靶基因,它逆转了miR-668-3p抑制剂对巨噬细胞极化和GC细胞生物学行为的影响。miR-668-3p在GC细胞中抑制NFKBIA,介导巨噬细胞的M2极化,从而促进GC的肿瘤发生。